Healthcare & Life Sciences

Virginia Subpoena Request Instructions for Board of Nursing Proceedings

The Virginia Department of Health Professions has issued instructions for requesting subpoenas in proceedings before the Board of Nursing. The guidance outlines the written request process, required information for witness testimony and document production, and delivery requirements to the Assistant Attorney General.

CA Board of Registered Nursing: Disclosure of Convictions and License Discipline

The California Board of Registered Nursing requires RNs to disclose any license discipline or criminal convictions sustained since their last renewal upon license renewal. This guidance details what constitutes a conviction, what types of license discipline must be reported, and the specific documentation required for disclosure.

CA Board of Registered Nursing Enforcement Press Releases

The California Board of Registered Nursing (BRN) has published a series of press releases detailing enforcement actions against individuals impersonating nurses or engaging in illegal practices. These releases highlight arrests for identity theft, illegal prescription issuance, and forging transcripts to obtain nursing credentials.

CA Board of Registered Nursing Enforcement: Unlicensed Practice Citations

The California Board of Registered Nursing has cited 134 individuals for unlicensed nursing practice and impersonation. These citations, issued under Business and Professions Code Sections 2795 and 2796, carry fines and penalties for practicing without an active RN license.

California DCA Enforcement Statistics and Performance Measures

The California Department of Consumer Affairs (DCA) has published updated enforcement statistics and performance measures for DCA licensees. These statistics track case volume, intake, investigation, formal discipline, and probation cycles, providing data for consumer protection efforts.

CA Board of Registered Nursing: Disciplinary Actions and Legal Terms

The California Board of Registered Nursing (BRN) has published a webpage explaining its disciplinary actions and related legal terminology. The page details the process for viewing disciplinary documents, defines terms such as 'Accusation' and 'Gross Negligence,' and outlines the factors considered when determining disciplinary penalties for registered nurses.

Iowa Board of Nursing Public Access Portal

The Iowa Board of Nursing has launched a new online portal for public access to nursing license and disciplinary documents. The portal allows the general public to verify licenses and view disciplinary actions without logging in, while other entities can create accounts for additional services.

Iowa Board of Nursing Complaint and Investigation Process

The Iowa Board of Nursing has published guidance detailing its complaint and investigation process for nursing professionals. The document outlines who can make a complaint, the types of violations the board investigates, and how to submit a complaint, including tips for patients and employers.

Iowa nursing disciplinary actions involve complaint review, sanctions, and reinstatement

Iowa nursing disciplinary actions involve complaint review, sanctions, and reinstatement

Iowa Board of Nursing Complaint Process and Discipline Documents

The Iowa Board of Nursing has published updated guidance on its complaint process, detailing who may make a complaint, how to submit one, and what types of issues are investigated. The document also provides tips for patients, employers, and law enforcement, and links to relevant forms and discipline documents.

Arkansas Nursing Board December 2025 disciplinary actions listed

Arkansas Nursing Board December 2025 disciplinary actions listed

Arkansas Nursing Board Disciplinary Actions - January 2026

The Arkansas State Board of Nursing has published its disciplinary actions for January 2026. The list includes various actions such as probation, letters of reprimand, suspension, voluntary surrender, and cease and desist orders against licensed nurses. Violations cited include professional misconduct and breaches of nursing standards.

New Mexico Medical Board Disciplinary Orders

The New Mexico Medical Board issued disciplinary orders between July 1, 2025, and September 30, 2025. Actions included stipulations for withdrawal of applications, notices of contemplated action for various violations, stipulated orders with reprimands and fines, and default orders of revocation.

New Mexico Medical Board Disciplinary Actions

The New Mexico Medical Board has issued several disciplinary orders, including license revocations, denials, and stipulations for the second quarter of 2025. These actions address violations of the Medical Practice Act, Impaired Health Care Provider Act, and Uniform Licensing Act, impacting licensed medical professionals in the state.

NM Medical Board Actions - Stipulations, Suspensions, Reprimands

The New Mexico Medical Board issued several disciplinary actions in Q4 2025, including stipulations of licensure with conditions, voluntary suspensions, interim consent agreements, and reprimands. These actions were taken following investigations into alleged violations of the Medical Practice Act.

NM Medical Board Actions: Fines, Suspensions, Revocations, Surrenders

The New Mexico Medical Board took various disciplinary actions against healthcare providers between January 1, 2024, and March 31, 2024. Actions included fines, license suspensions, revocations, and voluntary surrenders, often related to adverse actions in other states or failure to report such actions.

NM Medical Board Disciplinary Orders

The New Mexico Medical Board issued disciplinary orders and notices for multiple medical professionals between January 1, 2025, and March 31, 2025. Actions include notices of contemplated action, immediate suspensions, and orders of revocation based on alleged violations of the Medical Practice Act and related rules.

Georgia Medical Board Orders - February 2025

The Georgia Composite Medical Board issued two public orders in February 2025 concerning physician and physician assistant actions. These orders include a Public Consent Order for a physician and a Consent Agreement for Reinstatement for a physician assistant.

Georgia Medical Board Public Orders

The Georgia Composite Medical Board issued four public orders in January 2026, including consent orders and a consent agreement for licensure. These orders impose probation and specific conditions on licensed physicians and a senior laser practitioner.

Georgia Medical Board Orders - February 2026

The Georgia Composite Medical Board issued 12 public orders in February 2026, including final decisions, public consent orders, voluntary surrenders, and orders of summary suspension for physicians and physician assistants. One order details a final decision against Carlos Cossio, Sr., MD, for patient communication issues and a stalking conviction.

Pennsylvania Board of Medicine Professional Licensing and Actions

The Pennsylvania Board of Medicine provides information on professional licensing services, including applying for, renewing, and searching for licensed professionals via the PALS website. The document outlines the application process, including considerations for criminal history and the board's review and decision-making process for licensure.

Rabies vaccine recalled due to sterile water mix-up

The Rhode Island Department of Health announced a recall of a rabies vaccine due to a mix-up where sterile water was used instead of the vaccine. This recall affects healthcare providers and potentially patients who received the affected vaccine.

Organic Moringa Recalled Due to Salmonella Contamination

The Rhode Island Department of Health announced a recall of Organic Moringa products due to potential Salmonella contamination. Consumers are advised not to consume the product and to discard it or return it for a refund.

Navitas Organics chia seeds recalled for Salmonella contamination

The Rhode Island Department of Health announced a recall of Navitas Organics chia seeds due to potential Salmonella contamination. Consumers who purchased the affected product are advised not to consume it and to dispose of it or return it for a refund. This recall impacts food manufacturers, retailers, and importers.

Rhode Island Drug Overdose Data Update

The Rhode Island Department of Health has reported 55 non-fatal drug overdoses occurred in the state between March 10 and March 16. This data update provides situational awareness regarding the ongoing opioid crisis.

DEA Warns About Methamphetamine and Street Names

The DEA issued a public safety alert warning about methamphetamine, listing its various street names such as Crank, Crystal, and Ice. The alert directs readers to a DEA factsheet for more information on the drug and its effects.

DEA Public Safety Alert: Fentanyl Affects All Communities

The DEA issued a public safety alert via Twitter, emphasizing that fentanyl affects all communities regardless of race, age, or economic status. The alert, from DEA SAC D. Olesky, reiterates the DEA's goal of a fentanyl-free America and mentions a joint effort with Aurora Police to combat drug trafficking.

Iowa Safe Haven Law - 80 Infants Total

The Iowa Department of Health and Human Services announced that a baby girl was declared a safe haven in March, bringing the total to 80 infants since the law's inception. The notice reiterates the provisions of the Safe Haven Law and provides resources for prospective foster and adoptive parents.

DEA Notice of Application for Bulk Controlled Substance Manufacturer Registration

The DEA has published a notice regarding an application from Siegfried Grafton, Inc. to be registered as a bulk manufacturer of various controlled substances, including Schedule I and II drugs. Interested parties can submit comments or requests for a hearing by May 18, 2026.

DEA Notice: SpecGx LLC Importer Application for Controlled Substances

The DEA has issued a notice regarding an application from SpecGx LLC to be registered as an importer of Schedule II controlled substances, including Phenylacetone, Coca Leaves, Thebaine, Opium, Poppy Straw Concentrate, and Tapentadol. Interested parties can submit comments or objections by April 20, 2026.

DEA Bulk Manufacturer Application for Controlled Substances

The DEA has published a notice regarding an application from Sterling Wisconsin, LLC to be registered as a bulk manufacturer of Schedule I and II controlled substances, including Lysergic Acid Diethylamide, Marihuana Extract, and Oliceridine. Registered manufacturers and applicants can submit comments or hearing requests by May 18, 2026.

DEA Notice: Patheon API Services Importer Registration Application

The DEA has published a notice regarding an application from Patheon API Services, Inc. for registration as an importer of specific controlled substances, including Dimethyltryptamine, Psilocybin, Psilocyn, Amphetamine, and Methadone. Interested parties can submit comments or hearing requests by April 20, 2026.

Center for Scientific Review; Notice of Closed Meetings

The National Institutes of Health (NIH) Center for Scientific Review has announced upcoming closed meetings. These meetings are scheduled for April 16, 2026, and involve discussions related to grant applications and review processes.

National Institute of Diabetes and Digestive and Kidney Diseases; Closed Meeting Notice

The National Institutes of Health (NIH) has published a notice regarding a closed meeting for the National Institute of Diabetes and Digestive and Kidney Diseases. The meeting is scheduled for July 1, 2026. This notice serves as an informational announcement.

FDA Draft Guidance on New Approach Methodologies in Drug Development

The FDA has issued draft guidance for industry on the use of New Approach Methodologies (NAMs) in drug development. This guidance provides recommendations for sponsors on how to incorporate NAMs into their regulatory submissions. The comment period for this draft guidance closes on May 18, 2026.

FDA Proposed Collection of Information on Premarket Notifications

The FDA has proposed a new collection of information regarding premarket notifications. This is a request for comments on the proposed collection, with a deadline of May 18, 2026.

FDA Guidance on Pyrogen and Endotoxin Testing

The FDA has issued guidance for biological product, drug, and device firms regarding pyrogen and endotoxin testing. This document provides recommendations based on current FDA thinking concerning USP and AAMI standards for bacterial endotoxin and pyrogen tests.

Pennsylvania Delivers $6.6 Million for EMS Professionals

The Pennsylvania administration announced the delivery of $6.6 million to equip Emergency Medical Services (EMS) professionals across the Commonwealth. This funding, part of the 2025-26 budget, aims to recruit, train, and equip EMS personnel to improve response times and save lives.

WTC Health Program Denies Petition for Anti-GBM Glomerulonephritis

The Centers for Disease Control and Prevention (CDC) has issued a notice denying Petition 026 for the addition of Anti-Glomerular Basement Membrane (Anti-GBM) Glomerulonephritis to the World Trade Center (WTC) Health Program. The agency found insufficient evidence to support its inclusion.

WA DOH Revokes and Suspends Health Care Provider Licenses

The Washington State Department of Health has revoked and suspended licenses for several health care providers in February 2026 due to professional misconduct, including sexual misconduct, financial exploitation, and substance abuse. These actions impact providers across multiple counties and highlight the department's ongoing enforcement of licensing standards.

WA DOH Disciplinary Actions Against Health Care Providers

The Washington State Department of Health has taken disciplinary actions against several health care providers in March 2026. Actions include charges of unprofessional conduct, agreed orders to cease practice, and termination of probation. These actions address issues such as billing fraud, practicing without a credential, and inappropriate patient relationships.

Washington State Revokes, Suspends Health Care Provider Licenses

The Washington State Department of Health has revoked and suspended licenses and certifications for several health care providers. Actions include the indefinite suspension of a home care aide credential due to suspected theft and failure to respond to inquiries.

Washington State DOH Disciplines Health Care Providers

The Washington State Department of Health has taken disciplinary actions against several health care providers in March 2026. Actions include probation, denial of applications, and intent to issue cease-and-desist orders due to criminal convictions, unlicensed practice, and unprofessional conduct.

FDA Guidance on EpCAM-Positive Cell Reduction by Filters

The FDA has issued guidance concerning the reduction of EpCAM-positive cells by filters. This document provides information relevant to drug manufacturers and medical device makers.

FDA PRIA Reference Data

The FDA has published reference data related to the Prescription Drug User Fee Act (PRIA) for May 2024. This notice includes national employment data relevant to PRIA submissions. It serves as an informational update for regulated entities.

FDA Radiology Devices Classification Regulatory Analysis

The FDA has published a regulatory analysis concerning the classification of radiology devices. This notice provides an overview of the agency's approach to classifying these medical devices, offering clarity to manufacturers and stakeholders.

FDA Document on Biochemical Changes in Red Blood Cells

The FDA has posted a document concerning biochemical changes in red blood cells. The document is available for review on Regs.gov, though specific details are restricted due to copyright.

FDA Medical Device User Fee Rates for FY 2024

The Food and Drug Administration (FDA) has posted the Medical Device User Fee rates for Fiscal Year 2024. This notice provides the updated fee schedule for medical device manufacturers.

FDA Economic Analysis of CDRH Submission Requirements

The FDA has published an economic analysis concerning the submission requirements for the Center for Devices and Radiological Health (CDRH). This analysis provides insights into the economic impact of these requirements on medical device manufacturers.

FDA PRIA Reference SBA Size Standards Update

The FDA has posted an update regarding the Presolicitation Information and Analysis (PRIA) Reference, specifically concerning Small Business Administration (SBA) size standards. This notice updates the reference document used by the agency for certain regulatory processes.